Rigetti Faces Revenue Volatility and Rising Costs Despite Quantum Push

Rigetti's Q2 2026 revenue rose to $5.1 million from $1.8 million year over year, but 80% of sales came from two customers and recognition of its $8.4 million India C-DAC contract is deferred until Q4 installation and acceptance. Operating expenses increased 48% to $30.3 million, including a 53% rise in R&D to $20.7 million, driving a $28.1 million operating loss despite $541.3 million of liquidity. RGTI shares are down 31.1% year to date, trade at a 9.48x price-to-book premium to the industry, and carry a Zacks Rank #5 (Strong Sell).

Analysis

RGTI’s core issue is not liquidity but earnings quality: a project-based revenue model converts installation and customer-acceptance dates into binary quarterly outcomes, while the cost base is largely fixed. That creates a poor operating-leverage setup over the next 1-3 quarters—any delivery slippage disproportionately worsens reported losses and can reset sell-side revenue estimates, despite ample cash. The market is likely to value RGTI on proof of repeatable system demand and backlog conversion rather than headline quarterly growth.

IONQ appears better positioned for a relative rerating if enterprise security deployments develop into software, service, or appliance-related recurring revenue rather than one-off hardware sales. Conversely, the announced commercial agreement alone does not establish ARR, pricing, gross margin, or deployment timing; investors should demand evidence in bookings, deferred revenue, and customer concentration. SKYT has a modest positive read-through from quantum processor fabrication activity, but quantum remains too small to affect its investment case absent disclosed wafer volumes or a multiyear supply commitment.

The non-obvious risk to RGTI is that its cash balance can delay, rather than eliminate, valuation compression: management has capacity to sustain elevated R&D and capex before commercial utilization is proven. That reduces near-term financing risk but raises the probability that investors eventually apply a lower multiple to a cash-consuming research platform. A successful fourth-quarter acceptance event can produce a tactical bounce, but it would not falsify the structural short thesis unless it is accompanied by follow-on orders, improved gross margin, and a credible recurring-revenue mix.

Key Decisions for Investors

• Maintain an underweight/avoid stance on RGTI for the next 1-3 months; do not treat a delivery-driven fourth-quarter revenue recognition event as a fundamental inflection unless management discloses backlog growth, repeat customer orders, and materially improved revenue visibility.
• Consider a beta-adjusted pair trade: long IONQ / short RGTI over a 3-6 month horizon. The thesis is relative monetization quality and customer diversification, not a broad quantum-sector long; exit if IONQ fails to convert security partnerships into bookings or if RGTI demonstrates repeatable post-installation demand.
• For defined-risk bearish exposure to RGTI, monitor post-acceptance volatility for put-spread entry rather than shorting ahead of the binary milestone. The trade is attractive only if options liquidity and implied volatility permit a payout of at least 2:1; catalyst is a subsequent guidance reset or weak 2027 backlog commentary.
• Keep QBTS on a watch list rather than buying the funding headline. Reassess after the company quantifies grant milestones, matching-capital requirements, bookings conversion, and gross-margin recovery; failure on any of these would make the funding non-dilutive but economically insufficient.